A new in vitro approach for the simultaneous determination of phase I and phase II enzymatic activities of human hepatocyte preparations

Rapid Communications in Mass Spectrometry

Volumn 22, Issue 2, 2008, Pages 240-244

  Lahoz, Agustín ^a   Donato, Maria Teresa ^a,b   Montero, Sandra ^a   Castell, José V ^a,b   Gómez Lechón, Maria José ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; PHYSIOLOGY;

DRUG METABOLISMS; ENZYMATIC ACTIVITIES; HEPATOCYTES; HUMAN HEPATOCYTES; IN-VITRO; PHASE I; PHASE II; PRIMARY HEPATOCYTES; RAPID ASSESSMENT; SIMULTANEOUS DETERMINATIONS;

ENZYMES;

EID: 38549128284     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.3359     Document Type: Article

References (26)

1. Cashman JR, Zhang J. Annu. Rev. Pharmacol. Toxicol. 2006; 46: 65.
2. Krueger SK, Williams DE. Pharmacol. Ther. 2005; 106: 357.
3. Gonzalez FJ. Pharmacol. Ther. 1990; 45: 1.
4. Guengerich FP, Parikh A, Johnson EF, Richardson TH, von Wachenfeldt C, Cosme J, Jung F, Strassburg CP, Manns MP, Tukey RH, Pritchard M, Fournel-Gigleux S, Burchell B. Drug Metab. Dispos. 1997; 25: 1234.
5. Rendic S, Di Carlo FJ. Drug. Metab. Rev. 1997; 29: 413.
6. Rushmore TH, Kong AN. Curr. Drug Metab. 2002; 3: 481.
7. Zamek-Gliszczynski MJ, Hoffmaster KA, Nezasa K, Tallman MN, Brouwer KL. Eur. J. Pharm. Sci. 2006; 27: 447.
8. Gomez-Lechon MJ, Donato MT, Castell JV, Jover R. Curr. Drug Metab. 2004; 5: 443.
9. Gomez-Lechon MJ, Lahoz A, Jimenez N, Vicente Castell J, Donato MT. Xenobiotica 2006; 36: 457.
10. Terry C, Dhawan A, Mitry RR, Hughes RD. Cryobiology 2006; 53: 149.
11. Dierks EA, Stams KR, Lim HK, Cornelius G, Zhang H, Ball SE. Drug Metab. Dispos. 2001; 29: 23.
12. Bu HZ, Magis L, Knuth K, Teitelbaum P. Rapid Commun. Mass Spectrom. 2001; 15: 741.
13. Weaver R, Graham KS, Beattie IG, Riley RJ. Drug Metab. Dispos. 2003; 31: 955.
14. Testino SA Jr, Patonay G. J. Pharm. Biomed. Anal. 2003; 30: 1459.
15. Turpeinen M, Uusitalo J, Jalonen J, Pelkonen O. Eur. J. Pharm. Sci. 2005; 24: 123.
16. Kim MJ, Kim H, Cha IJ, Park JS, Shon JH, Liu KH, Shin JG. Rapid Commun. Mass Spectrom. 2005; 19: 2651.
17. Tolonen A, Petsalo A, Turpeinen M, Uusitalo J, Pelkonen O. J. Mass Spectrom. 2007; 42: 960.
18. Lahoz A, Donato MT, Picazo L, Gomez-Lechon MJ, Castell JV. Toxicol. In Vitro 2007; 21: 1247.
19. Lahoz A, Gombau L, Donato MT, Castell JV, Gomez-Lechon MJ. Mini Rev. Med. Chem. 2006; 6: 1053.
20. Wang Q, Jia R, Ye C, Garcia M, Li J, Hidalgo IJ. In Vitro Cell. Dev. Biol. Anim. 2005; 41: 97.
21. Wang Q, Ye C, Jia R, Owen AJ, Hidalgo IJ, Li J. In Vitro Cell. Dev. Biol. Anim. 2006; 42: 8.
22. Donato MT, Castell JV. Clin. Pharmacokinet. 2003; 42: 153.
23. Walsky RL, Obach RS. Drug Metab. Dispos. 2004; 32: 647.
24. Yuan R, Madani S, Wei XX, Reynolds K, Huang SM. Drug Metab. Dispos. 2002; 30: 1311.
25. Floby E, Briem S, Terelius Y, Sohlenius-Sternbeck AK. Xenobiotica 2004; 34: 949.
26. Wang LQ, James MO. Curr. Drug Metab. 2006; 7: 83.